Editöre Mektup: ‘Hipertansiyon Tanılı Covid-19 Hastalarında Biyokimyasal Parametrelerin İncelenmesi’

Year 2023, Volume: 13 Issue: 4, 584 - 586, 30.12.2023

Ali Kırık , Özge Kama Başcı , Ayse Ergene , Hacer Şen

https://doi.org/10.31832/smj.1191209

https://izlik.org/JA43HW98MT

Abstract

....................................................................................................................................................

Keywords

covid-19 , hipertansiyon , mortalite

Supporting Institution

..

Project Number

..

Thanks

..

References

• 1. Çekiç D, Genç AC, İşsever K ve ark. Hipertansiyon tanılı Covid-19 hastalarında fibrinojen ve d-dimer düzeylerinin incelenmesi. Sak Tıp D. Doi:10.31832/SMJ.953008
• 2. Leca BM, Mytilinaiou M, Tsoli M, et al. Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis. Sci Reports |. 123AD;11:9801. doi:10.1038/s41598-021-89256-7
• 3. Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al. Open access diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021;11:52777. doi:10.1136/bmjopen-2021-052777
• 4. Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19 related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death. United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355-361. doi:10.15585/MMWR.MM7010E4
• 5. Schutte T, Thijs A, Smulders YM. Never ignore extremely elevated d-dimer levels: They are specific for serious illness. Neth J Med. 2016;74(10):443-448.